Skip to main content

Advertisement

Table 2 Comparison the mean score for QoL and the VAS scale according to the patients’ demographic characteristics by sex

From: The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand

characteristicsED-Q5VAS
malefemaletotalmalefemaletotal
Mean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SD
Age group≤50y0.98 ± 0.030.91 ± 0.090. 93 ± 0.0874.11 ± 6.1166.41 ± 9.7168.75 ± 9.54
51-60y0.95 ± 0.080.83 ± 0.150.87 ± 0.1470.71 ± 9.7261.18 ± 8.9164.50 ± 10.24
> 600.89 ± 0.140.86 ± 0.120.88 ± 0.1366.19 ± 6.4562.33 ± 8.7664.28 ± 7.89
F 4.434.494.008.944.385.09
P value 0.010.010.01< 0.0010.010.007
JobEmployed0.94 ± 0.110.93 ± 0.070.94 ± 0.1070.93 ± 8.2267.77 ± 11.2770.19 ± 9.04
housewife0.87 ± 0.120.87 ± 0.1262.38 ± 8.6262.38 ± 8.62
others0.90 ± 0.130.72 ± 0.210.87 ± 0.1663.90 ± 7.7460.00 ± 11.0165.57 ± 8.82
F or T 1.8911.388.763.573.5319.95
P value 0.06< 0.001< 0.0010.0020.03< 0.001
Education LevelIlliterate0.88 ± 0.130.87 ± 0.130.87 ± 0.1366.87 ± 11.3160.90 ± 8.3761.72 ± 8.96
undergraduate0.91 ± 0.140.88 ± 0.100.89 ± 0.1267.17 ± 7.1663.63 ± 8.5665.07 ± 8.18
postgraduate0.94 ± 0.080.80 ± 0.180.88 ± 0.1571.15 ± 8.4362.97 ± 11.6365.75 ± 10.36
F 1.445.050.733.731.437.70
P value 0.240.0070.470.020.240.001
Treatment typeOral drug0.93 ± 0.120.87 ± 0.130.89 ± 0.1369.42 ± 8.4663.12 ± 9.5265.85 ± 9.46
insulin0.91 ± 0.110.83 ± 0.140.86 ± 0.1366.85 ± 6.9561.57 ± 8.3763.55 ± 8.23
T 0.622.222.281.010.891.37
P value 0.530.020.020.300.360.16
HbA1C< 70.96 ± 0.040.86 ± 0.160.89 ± 0.1470.55 ± 7.2563.84 ± 9.2065.96 ± 9.13
≥70.92 ± 0.130.86 ± 0.120.88 ± 0.1368.55 ± 8.3562.41 ± 9.2765.06 ± 9.39
T 2.840.010.470.950.850.66
P value 0.0060.990.630.300.390.50
DM history<10y0.95 ± 0.070.87 ± 0.120.90 ± 0.1169.93 ± 7.7863.91 ± 9.0966.43 ± 9.42
≥10y0.88 ± 0.170.84 ± 0.140.85 ± 0.1666.86 ± 6.6360.80 ± 9.2463.15 ± 8.81
T 2.41.612.832.002.202.98
P value 0.020.100.0050.040.040.003